Published online Dec 25, 2023. doi: 10.5527/wjn.v12.i5.159
Peer-review started: August 5, 2023
First decision: September 19, 2023
Revised: September 21, 2023
Accepted: October 23, 2023
Article in press: October 23, 2023
Published online: December 25, 2023
Processing time: 138 Days and 22.3 Hours
There are a number of methods by which the quantification of protein excretion in urine is done to inform clinical decisions. Among these, the estimation of protein excretion in the 24-h urinary sample is the traditional and gold standard method. However, it is cumbersome, time-consuming, and prone to errors. The alternative method of measuring urine protein-to-creatinine ratio (uPCR) is used widely in clinical practice as it is quick, patient-friendly, and reliable. The available data on the correlation between the above two methods is controversial.
We also heavily rely on uPCR for our routine patient care. However, we do not know how it correlates with 24-h urinary protein excretion. This motivated us to determine the correlation and degree of agreement between the two tests, so that we should use uPCR results accordingly.
The objectives of this study were to determine the correlation of spot uPCR with 24-h urinary protein excretion test and in particular, the degree of agreement between the two tests, in patients suffering from various forms of glomerulopathies so that we may use this test with caution in future.
This was a cross-sectional, observational study conducted on all newly presenting adult patients (age: 18 to 60 years) with proteinuria who were being investigated for suspected glomerulonephritis (GN). All patients were counseled regarding 24-h urine collection. A spot urine sample was collected the next day at the time of submission of a 24-h urine sample for measuring uPCR along with a blood sample. SPSS version 20.0 was used for statistical analysis.
A total of 157 patients with a mean age of 30.45 ± 12.11 years were included. There were 94 (59.8%) males and 63 (40.2%) females. The mean 24-h urinary protein excretion was 3192.78 ± 1959.79 mg and the mean spot uPCR was 3.16 ± 1.52 in all patients. A significant but poor correlation was observed between spot uPCR and 24-h urinary protein excretion (r = 0.342, P = 0.01) among all patients. On subgroup analysis, a slightly better correlation was found in patients older than 47 years (r = 0.78), and those with body mass index > 25 kg/m2 (r = 0.45). Bland and Altman's plot analysis of the two tests also showed a wide range of the limits of agreement between the two methods.
The results from this study show a significant, positive but poor correlation between spot uPCR and 24-h urinary protein estimation in various types of glomerular diseases. The agreement between the two methods was also poor. Hence, there is a need for careful interpretation of the ratio in an unselected group of patients with glomerular diseases.
There is a need to conduct a well-planned, international, multi-center study to resolve the controversy of correlation and agreement between the two most widely used methods of proteinuria estimation in clinical practice.